Linker– tag –
-
Lonza Expands Commercial ADC Payload-Linker Manufacturing Capacity at Visp to Support Growing Oncology Pipeline
BioPharma APAC Switzerland Overview CDMO giant Lonza has announced significant expansion plans for its commercial antibody-drug conjugate (ADC) payload-linker manufacturing capacity at its Visp, Switzerland, site. This strategic investme... -
Lonza Significantly Boosts ADC Manufacturing Capacity at Swiss Visp Site, Expanding Payload-Linker Production and Launching New Commercial Facility by 2028
Fierce Pharma Switzerland Overview Lonza announced a significant expansion of its ADC manufacturing capacity, extending a partnership with a major US drugmaker to meet the growing demand in the antibody-drug conjugate market. At its Visp... -
ADC Technology Evolves: Data-Driven Design from Antigen Selection to AI-Assisted Engineering Transforms Therapeutic Paradigm
MDPI Unknown Overview Antibody-drug conjugates (ADCs) have evolved into a mature therapeutic platform with exponentially increasing clinical relevance. This review highlights recent advances in ADC design and development, emphasizing the... -
Antibody-Drug Conjugate (ADC) Field Enters Era of Diversification in 2025: 130 New ADC Candidates Advance to Clinical Development, Total Reaches 2,334
ChemExpress (citing Beacon ADC database) China Overview In 2025, the Antibody-Drug Conjugate (ADC) field experienced a significant paradigm shift, transitioning from platform validation to an era of diversification. The total number of t... -
NEOK002: Next-Generation Bispecific ADC Targeting EGFR and MUC1 Enters Clinical Development for Solid Tumors
Conference Coverage AACR USA Overview NEOK002 (formerly ABL209), a bispecific antibody-drug conjugate (ADC), has entered clinical development, designed to concurrently target two key cancer antigens, EGFR and MUC1, implicated in epitheli... -
Synthetic Small Molecule API Market to See Growth through 2035, Driven by Oncology Pipeline and Generic Demand, Report Says
IndexBox Global Overview This article provides an overview of a market research report published by IndexBox, which forecasts growth in the global synthetic small molecule API market, driven by increasing chronic disease prevalence, a ro...
